High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach.

Phosphodiesterase-5 inhibitors (PDE-5I) have demonstrated improvement in disease symptoms and quality of life for patients with pulmonary arterial hypertension (PAH). Despite these benefits, reported adherence to PDE-5I therapy is sub-optimal. Clinical pharmacists at an integrated practice site are...

Full description

Bibliographic Details
Main Authors: Nisha B Shah, Rhonita E Mitchell, Stephanie Terry Proctor, Leena Choi, Joshua DeClercq, Jacob A Jolly, Anna R Hemnes, Autumn D Zuckerman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0217798

Similar Items